Skip to main content
Vita 34 AG logo

Vita 34 AG — Investor Relations & Filings

Ticker · V3V ISIN · DE000A0BL849 LEI · 529900OEWA4GSZEZ4P40 F Human health and social work activities
Filings indexed 794 across all filing types
Latest filing 2018-03-21 Report Publication Anno…
Country DE Germany
Listing F V3V

About Vita 34 AG

https://www.vita34.de/en/

Vita 34 AG is a biobank specializing in the cryopreservation of stem cells derived from umbilical cord blood and tissue. Established in 1997 as the first private cord blood bank in Europe, the company offers services for the long-term storage of perinatal stem cells for potential future medical applications. The service portfolio includes providing collection kits for childbirth, handling logistics, processing the biological material, and storing the stem cell deposits under cryogenic conditions. These services are offered to expectant parents as a form of private medical provision for their child and family. As part of the Famicord Group, Vita 34 is also involved in research and development related to cell-based therapies.

Recent filings

Filing Released Lang Actions
Datum:21.03.2018
Report Publication Announcement Classification · 100% confidence The document is a short notification (under 1,000 characters) titled 'Hinweis auf Jahresfinanzbericht' (Notice regarding the Annual Financial Report). It provides the publication date and a URL link to access the actual report on the company's website. Following the 'Menu vs Meal' rule, this is an announcement of a report rather than the report itself, making it a Report Publication Announcement (RPA).
2018-03-21 German
Major Shareholding Notification 2018
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections detailing the 'Notification of Major Holdings' as per Article 40, Section 1 of the WpHG (German Securities Trading Act). It reports changes in the percentage of voting rights held by a specific shareholder ('Human Stem Cells Institute PJSC') in Vita 34 AG, including details on shares and instruments. This directly corresponds to the definition of reporting changes in significant share ownership levels, which maps to the Major Shareholding Notification category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the content is a detailed disclosure of shareholding changes, making MRQ the most precise fit over DVA (which is for voting results) or RNS (the general fallback).
2018-02-20 English
Declaration of Voting Results & Voting Rights Announcements 2018
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' under German securities law (WpHG). It details changes in voting rights percentages (e.g., 4.74%, 5.4%) held by a specific shareholder (Human Stem Cells Institute PJSC). This directly corresponds to the definition of reporting changes in significant share ownership levels, which maps to the Major Shareholding Notification category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the content is a formal notification of a holding threshold crossing, not the results of a vote (DVA).
2018-02-20 English
Satzung 2018
Governance Information Classification · 98% confidence The document text provided is titled "SATZUNG" (Statutes/Bylaws) for "Vita 34 AG". It contains a detailed table of contents and the full text of various sections (§1 through §16 are visible) outlining the company's fundamental rules, including its name, purpose, share capital structure, composition and duties of the Management Board (Vorstand) and Supervisory Board (Aufsichtsrat), and rules for the General Meeting (Hauptversammlung). This structure is characteristic of a company's Articles of Association or Bylaws, which define the legal framework and governance structure of the corporation. This type of foundational document is best classified under Governance Information (CGR), as it details the internal rules and structure of the company, distinct from periodic financial reports (10-K, IR) or specific event announcements (AGM-R, DIV).
2018-01-24 German
Articles of Association (in German) 2018
Governance Information Classification · 98% confidence The document text provided is titled "SATZUNG" (Statutes/Bylaws) for "Vita 34 AG". It contains a detailed table of contents and the full text of various sections (§1 through §16 are visible) outlining the company's fundamental rules, including its name, purpose, share capital structure, composition and duties of the Management Board (Vorstand) and Supervisory Board (Aufsichtsrat), and rules for the General Meeting (Hauptversammlung). This structure is characteristic of a company's Articles of Association or Bylaws, which define the legal framework and governance structure of the corporation. This type of foundational document is best classified under Governance Information (CGR), as it details the internal rules and structure of the company, distinct from periodic financial reports (10-K, IR) or specific event announcements (AGM-R, DIV).
2018-01-24 English
DGAP-DD: Vita 34 AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section labeled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the name of an individual (Frank Köhler), their position ('Member of the administrative or supervisory body'), the nature of the transaction ('Acquisition'), and specific details about the shares bought, including price and volume. This content directly matches the definition for Director's Dealing.
2018-01-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.